Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02813434
PHASE3

Cerebral Amyloid Imaging Using Florbetapir (AV-45)

Sponsor: Centre Hospitalier Universitaire, Amiens

View on ClinicalTrials.gov

Summary

This study is aimed at examining the interest of amyloid radiotracer Florbetapir (18F-AV-45) for the etiological diagnosis of poststroke cognitive impairment and dementia

Official title: Cerebral Amyloid Imaging Using Florbetapir (18F-AV-45) for the Etiological Diagnosis of Poststroke Cognitive Impairment and Dementia

Key Details

Gender

All

Age Range

40 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

92

Start Date

2014-09-24

Completion Date

2025-01-07

Last Updated

2026-06-11

Healthy Volunteers

No

Interventions

BIOLOGICAL

florbetapir

18F-AV-45 or 18F-Florbetapir

Locations (1)

CHU Amiens

Amiens, France